KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Operating Expenses (2016 - 2026)

Evolent Health has reported Operating Expenses over the past 11 years, most recently at $877.0 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 31.84% year-over-year to $877.0 million; the TTM value through Dec 2025 reached $2.3 billion, down 11.9%, while the annual FY2025 figure was $2.3 billion, 11.9% down from the prior year.
  • Operating Expenses for Q4 2025 was $877.0 million at Evolent Health, up from $478.6 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $877.0 million in Q4 2025 and troughed at $229.1 million in Q3 2021.
  • A 5-year average of $460.8 million and a median of $462.1 million in 2025 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: plummeted 48.16% in 2021 and later surged 55.74% in 2023.
  • Year by year, Operating Expenses stood at $260.6 million in 2021, then skyrocketed by 47.49% to $384.3 million in 2022, then surged by 50.24% to $577.4 million in 2023, then rose by 15.19% to $665.1 million in 2024, then surged by 31.84% to $877.0 million in 2025.
  • Business Quant data shows Operating Expenses for EVH at $877.0 million in Q4 2025, $478.6 million in Q3 2025, and $445.5 million in Q2 2025.